• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于 SUMOylation 调节剂的低级别胶质瘤预后模型的构建。

Construction of a SUMOylation regulator-based prognostic model in low-grade glioma.

机构信息

Department of Neurosurgery, Shengjing Hospital of China Medical University, Shenyang, China.

Department of Stomatology, Shengjing Hospital of China Medical University, Shenyang, China.

出版信息

J Cell Mol Med. 2021 Jun;25(12):5434-5442. doi: 10.1111/jcmm.16553. Epub 2021 May 5.

DOI:10.1111/jcmm.16553
PMID:33951297
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8184686/
Abstract

Low-grade glioma (LGG) is an intracranial malignant tumour that mainly originates from astrocytes and oligodendrocytes. SUMOylation is one of the post-translational modifications but studies of SUMOylation in LGG is quite limited. Transcriptome data, single nucleotide variant (SNV) data and clinical data of LGG were derived from public databases. The differences between the expression of SUMOylation regulators in LGG and normal brain tissue were analysed. Cox regression was used to construct a prognostic model in the training cohort. Kaplan-Meier survival curves and ROC curves were plotted in the training and the validation cohort to evaluate the effectiveness of the prognostic model. GO and KEGG analyses were applied to preliminarily analyse the biological functions. Compared with normal brain tissue, SENP1 and SENP7 were up-regulated and SENP5 was down-regulated in LGG. SUMOylation regulators may be involved in functions such as mRNA splicing, DNA replication, ATPase activity and spliceosome. One prognostic model was established based on the 4 SUMOylation regulator-related signatures (RFWD3, MPHOSPH9, WRN and NUP155), which had a good predictive ability for overall survival. This study is expected to provide targets for the diagnosis and treatment of low-grade glioma.

摘要

低级别胶质瘤(LGG)是一种颅内恶性肿瘤,主要起源于星形胶质细胞和少突胶质细胞。SUMOylation 是翻译后修饰之一,但 LGG 中的 SUMOylation 研究相当有限。LGG 的转录组数据、单核苷酸变异(SNV)数据和临床数据均来自公共数据库。分析了 LGG 中 SUMOylation 调节因子的表达差异。在训练队列中使用 Cox 回归构建预后模型。在训练和验证队列中绘制 Kaplan-Meier 生存曲线和 ROC 曲线,以评估预后模型的有效性。GO 和 KEGG 分析用于初步分析生物学功能。与正常脑组织相比,SENP1 和 SENP7 在 LGG 中上调,而 SENP5 下调。SUMOylation 调节因子可能参与 mRNA 剪接、DNA 复制、ATPase 活性和剪接体等功能。基于 4 个 SUMOylation 调节因子相关特征(RFWD3、MPHOSPH9、WRN 和 NUP155)建立了一个预后模型,该模型对总生存期具有良好的预测能力。本研究有望为低级别胶质瘤的诊断和治疗提供新的靶点。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6ff7/8184686/624a33bc84ec/JCMM-25-5434-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6ff7/8184686/cfee51bbf0be/JCMM-25-5434-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6ff7/8184686/9c54bf228fe2/JCMM-25-5434-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6ff7/8184686/ef335a882a05/JCMM-25-5434-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6ff7/8184686/defe148f19aa/JCMM-25-5434-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6ff7/8184686/0742d6b9c868/JCMM-25-5434-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6ff7/8184686/624a33bc84ec/JCMM-25-5434-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6ff7/8184686/cfee51bbf0be/JCMM-25-5434-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6ff7/8184686/9c54bf228fe2/JCMM-25-5434-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6ff7/8184686/ef335a882a05/JCMM-25-5434-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6ff7/8184686/defe148f19aa/JCMM-25-5434-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6ff7/8184686/0742d6b9c868/JCMM-25-5434-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6ff7/8184686/624a33bc84ec/JCMM-25-5434-g005.jpg

相似文献

1
Construction of a SUMOylation regulator-based prognostic model in low-grade glioma.基于 SUMOylation 调节剂的低级别胶质瘤预后模型的构建。
J Cell Mol Med. 2021 Jun;25(12):5434-5442. doi: 10.1111/jcmm.16553. Epub 2021 May 5.
2
Development of a nomogram for prognostic prediction of lower-grade glioma based on alternative splicing signatures.基于剪接变异特征的低级别胶质瘤预后预测列线图的构建。
Cancer Med. 2020 Dec;9(24):9266-9281. doi: 10.1002/cam4.3530. Epub 2020 Oct 13.
3
Identification and validation of a novel eight mutant-derived long non-coding RNAs signature as a prognostic biomarker for genome instability in low-grade glioma.鉴定和验证一种新型的八个突变衍生的长非编码 RNA 特征作为低级别胶质瘤基因组不稳定性的预后生物标志物。
Aging (Albany NY). 2021 Jun 3;13(11):15164-15192. doi: 10.18632/aging.203079.
4
An NF-κB signature predicts low-grade glioma prognosis: a precision medicine approach based on patient-derived stem cells.基于患者来源的干细胞的精准医学方法:一个预测低级别神经胶质瘤预后的 NF-κB 特征。
Neuro Oncol. 2018 May 18;20(6):776-787. doi: 10.1093/neuonc/nox234.
5
Identification of Prognostic Signatures of Alternative Splicing in Glioma.胶质瘤中可变剪接预后特征的鉴定
J Mol Neurosci. 2020 Oct;70(10):1484-1492. doi: 10.1007/s12031-020-01581-0. Epub 2020 Jun 29.
6
A Novel 10-Gene Signature Predicts Poor Prognosis in Low Grade Glioma.一种新的 10 基因标志物可预测低级别胶质瘤的不良预后。
Technol Cancer Res Treat. 2021 Jan-Dec;20:1533033821992084. doi: 10.1177/1533033821992084.
7
Identification of Critical mA RNA Methylation Regulators with Prognostic Value in Lower-Grade Glioma.低级别胶质瘤中具有预后价值的关键 mA RNA甲基化调控因子的鉴定
Biomed Res Int. 2021 Jun 8;2021:9959212. doi: 10.1155/2021/9959212. eCollection 2021.
8
Serine Incorporator 2 (SERINC2) Expression Predicts an Unfavorable Prognosis of Low-Grade Glioma (LGG): Evidence from Bioinformatics Analysis.丝氨酸掺入因子 2(SERINC2)表达预测低级别胶质瘤(LGG)的不良预后:来自生物信息学分析的证据。
J Mol Neurosci. 2020 Oct;70(10):1521-1532. doi: 10.1007/s12031-020-01620-w. Epub 2020 Jul 8.
9
SYT16 is a prognostic biomarker and correlated with immune infiltrates in glioma: A study based on TCGA data.SYT16 是胶质母细胞瘤的预后生物标志物,并与免疫浸润相关:基于 TCGA 数据的研究。
Int Immunopharmacol. 2020 Jul;84:106490. doi: 10.1016/j.intimp.2020.106490. Epub 2020 Apr 11.
10
SHOX2 is a Potent Independent Biomarker to Predict Survival of WHO Grade II-III Diffuse Gliomas.SHOX2是预测世界卫生组织II-III级弥漫性胶质瘤患者生存的有效独立生物标志物。
EBioMedicine. 2016 Nov;13:80-89. doi: 10.1016/j.ebiom.2016.10.040. Epub 2016 Oct 28.

引用本文的文献

1
SENP1: A perspective from immune cells to disease (Review).SENP1:从免疫细胞到疾病的视角(综述)。
Oncol Rep. 2025 Sep;54(3). doi: 10.3892/or.2025.8947. Epub 2025 Jul 19.
2
Prognostic value of CTF1 in glioma and its role in the tumor microenvironment.CTF1在胶质瘤中的预后价值及其在肿瘤微环境中的作用。
Transl Cancer Res. 2024 Dec 31;13(12):6862-6879. doi: 10.21037/tcr-24-1258. Epub 2024 Dec 27.
3
Overexpression of GINS4 is associated with poor prognosis and survival in glioma patients.GINS4 的过表达与胶质瘤患者的不良预后和生存相关。

本文引用的文献

1
Adult Diffuse Low-Grade Gliomas: 35-Year Experience at the Nancy France Neurooncology Unit.成人弥漫性低级别胶质瘤:法国南锡神经肿瘤学单位35年的经验
Front Oncol. 2020 Oct 28;10:574679. doi: 10.3389/fonc.2020.574679. eCollection 2020.
2
Early atypical malignant transformation of diffuse low-grade astrocytoma: The importance of genotyping.弥漫性低级别星形细胞瘤的早期非典型恶性转化:基因分型的重要性。
Neurocirugia (Engl Ed). 2020 Nov 5. doi: 10.1016/j.neucir.2020.09.003.
3
SUMOylation of HSP27 regulates PKM2 to promote esophageal squamous cell carcinoma progression.
Mol Med. 2021 Sep 23;27(1):117. doi: 10.1186/s10020-021-00378-0.
4
Establishment of an Immune-Related Gene Signature for Risk Stratification for Patients with Glioma.建立用于胶质瘤患者风险分层的免疫相关基因特征。
Comput Math Methods Med. 2021 Aug 27;2021:2191709. doi: 10.1155/2021/2191709. eCollection 2021.
SUMOylation 调控 HSP27 稳定 PKM2 促进食管鳞癌进展
Oncol Rep. 2020 Oct;44(4):1355-1364. doi: 10.3892/or.2020.7711. Epub 2020 Jul 31.
4
The SUMO-specific protease SENP1 deSUMOylates p53 and regulates its activity.SUMO 特异性蛋白酶 SENP1 去 SUMO 化 p53 并调节其活性。
J Cell Biochem. 2021 Feb;122(2):189-197. doi: 10.1002/jcb.29838. Epub 2020 Aug 12.
5
Sumoylation on its 25th anniversary: mechanisms, pathology, and emerging concepts.SUMO 化修饰:机制、病理学和新兴概念,迎来 25 周年纪念。
FEBS J. 2020 Aug;287(15):3110-3140. doi: 10.1111/febs.15319. Epub 2020 May 1.
6
Molecular mechanisms in SUMO conjugation.SUMO 连接中的分子机制。
Biochem Soc Trans. 2020 Feb 28;48(1):123-135. doi: 10.1042/BST20190357.
7
The landscape of postsurgical recurrence patterns in diffuse low-grade gliomas.弥漫性低级别胶质瘤术后复发模式的研究现状。
Crit Rev Oncol Hematol. 2019 Jun;138:148-155. doi: 10.1016/j.critrevonc.2019.04.009. Epub 2019 Apr 15.
8
Introduction to Sumoylation.SUMO化修饰简介。
Adv Exp Med Biol. 2017;963:1-12. doi: 10.1007/978-3-319-50044-7_1.
9
Inhibition of SUMO-specific protease 1 induces apoptosis of astroglioma cells by regulating NF-κB/Akt pathways.小泛素样修饰特异性蛋白酶1的抑制通过调节NF-κB/Akt信号通路诱导星形胶质瘤细胞凋亡。
Gene. 2016 Dec 31;595(2):175-179. doi: 10.1016/j.gene.2016.09.040. Epub 2016 Sep 28.
10
Sumoylation of eIF4A2 affects stress granule formation.真核翻译起始因子4A2(eIF4A2)的类泛素化修饰影响应激颗粒的形成。
J Cell Sci. 2016 Jun 15;129(12):2407-15. doi: 10.1242/jcs.184614. Epub 2016 May 9.